Structural Heart Closure Devices | Market Insights | Asia Pacific (Supplemental) | 2024
Although the global COVID-19 pandemic negatively impacted the Asia Pacific structural heart closure device market in 2020, strong prepandemic growth trends in the PFO and LAA segments helped to sustain positive overall procedure volume and market growth for the year, and the market has subsequently shown strong recovery. Going forward, the market will continue to expand through 2032, supported by continued robust growth in the well-established Australian market, expanding evidence demonstrating the safety and efficacy of transcatheter and epicardial structural heart closure procedures, the introduction of new devices, and growing competition from and the strong presence of domestic manufacturers offering low-cost products in the large and expanding Chinese market.
This Medtech 360 Report provides comprehensive data and analysis on the state of the structural heart closure device market in Asia Pacific from 2019 through 2032.
